Evidence map›Paper›PMID 40652294›Full record

ArticleBiology of reproduction2025

The nuclear transport factor IPO5 revealed as a critical mediator of male germline development†.

Julia C Young, Penny A F Whiley, Jessie M Sutherland, Michael Luu, Daniel J Garama, Mark A Baker, Cathryn A Hogarth, Elizabeth A Richards, David A Jans, Eileen A McLaughlin and 1 more

Abstract read
In one paragraph

Article in Biology of reproduction, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Julia C YoungCentre for Reproductive Health, Hudson Institute for Medical Research, Clayton, VIC, Australia.ORCID 0000-0001-7219-7824
Penny A F WhileyCentre for Reproductive Health, Hudson Institute for Medical Research, Clayton, VIC, Australia.
Jessie M SutherlandSchools of Biomedical Science and Pharmacy and Environmental and Life Sciences, University of Newcastle, Callaghan, NSW, Australia.
Michael LuuCentre for Reproductive Health, Hudson Institute for Medical Research, Clayton, VIC, Australia.
Daniel J GaramaCentre for Reproductive Health, Hudson Institute for Medical Research, Clayton, VIC, Australia.
Mark A BakerSchools of Biomedical Science and Pharmacy and Environmental and Life Sciences, University of Newcastle, Callaghan, NSW, Australia.
Cathryn A HogarthDepartment of Rural Clinical Sciences, La Trobe Rural Health School, La Trobe University, Wodonga, VIC, Australia.
Elizabeth A RichardsDepartment of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.
David A JansDepartment of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia.
Eileen A McLaughlinSchools of Biomedical Science and Pharmacy and Environmental and Life Sciences, University of Newcastle, Callaghan, NSW, Australia.
Kate L LovelandCentre for Reproductive Health, Hudson Institute for Medical Research, Clayton, VIC, Australia.ORCID 0000-0002-5750-8046

Funding

Australian National Health and Medical Research Council APP1079646Australian Research Council Centre of Excellence in Biotechnology and Development CE0348239the Australian Research Council DP200103463Victorian State Government Operational Infrastructure Scheme
6 · The paper itself

Abstract

The highly conserved nuclear transport protein importin 5 (IPO5) binds cargo implicated in fundamental processes including virus and chromatin assembly, germline development, and cell signaling. It also anchors cell-specific cargo for functional outcomes in development and immune responses. IPO5 displays both spatial and temporal regulation in the male germline, from fetal through to adult ages. Because it transports key early developmental/reproductive factors, including Stella and the BMP signaling SMADs 1/5/9, we hypothesized that targeted IPO5 deletion would impair germline development and viability at specific stages. Here, we demonstrate in vivo functional importance of IPO5 by generating global and conditional IPO5 knockout mice using an Ipo5FL/FL allele flanking exons 9 and 10. Global deletion using CMVCre produced no null embryos at embryonic day (E)12.5, while heterozygous embryo numbers were reduced to 50%, demonstrating it is essential for early embryogenesis. A sex-specific germline requirement for IPO5 was demonstrated following deletion using VasaCre (active from E15.5); adult testes lacked germ cells, while oocytes developed and female fertility was unaffected. Stra8Cre-directed IPO5 deletion (active from postnatal day (PND) 3) caused meiotic failure evident at PND 14; no IPO5-deficient germ cells were present in adults, although niche integrity and function supported emergence of rare IPO5-positive spermatozoa. Novel IPO5 binding proteins identified by immunoprecipitation and mass-spectrometry included SFPQ in fetal testes and XPO2 (exportin 2) in both isolated spermatocytes and spermatids. Remarkably, most IPO5 potential binding proteins are essential for male fertility. These results define IPO5 as crucial for in vivo embryonic development and male fertility.

Indexed as

Germ CellsKaryopherinsSpermatozoaAnimalsEmbryonic DevelopmentFemaleGene Expression Regulation, DevelopmentalMaleMiceMice, KnockoutSpermatogenesisKaryopherinsembryogenesisgerm cellimportinnuclear transportspermatogenesisspermiogenesistestis

Identifiers

PMID40652294
PMCPMC12527242

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.